Buscar
Koninklijke Philips NV
PHGAñadir a la lista de seguimiento
24.970USD
+0.070+0.28%
Cierre 09-22 16:00（ET）
24.42BCap. mercado
21.47P/E TTM
Fuera de horario 19:00 (ET)24.970USD-0.030-0.12%
Fuera de horario 19:00 (ET)Acerca de {index_name} Koninklijke Philips NV Compañía
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Perfil de Koninklijke Philips NV
Símbolo de cotizaciónPHG
Nombre de la empresaKoninklijke Philips NV
Fecha de salida a bolsaSep 18, 2009
Director ejecutivoJakobs (Roy)
Número de empleados67823
Tipo de seguridadDepository Receipt
Fin del año fiscalSep 18
DirecciónHigh Tech Campus 5
CiudadEINDHOVEN
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísNetherlands
Código postal5656 AE
Teléfono31205977777
Sitio Webhttps://www.philips.com/
Símbolo de cotizaciónPHG
Fecha de salida a bolsaSep 18, 2009
Director ejecutivoJakobs (Roy)
Ejecutivos de Koninklijke Philips NV
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Chief ESG & Legal Officer, Member of the Board of Management
Chief ESG & Legal Officer, Member of the Board of Management
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Management Board, President, Chief Executive Officer
Chairman of the Management Board, President, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader Diagnosis and Treatment
Executive Vice President, Chief Business Leader Diagnosis and Treatment
--
--
Ms. Deeptha Khanna
Ms. Deeptha Khanna
Executive Vice President, Chief Business Leader Personal Health
Executive Vice President, Chief Business Leader Personal Health
--
--
Mr. Peter Loescher
Mr. Peter Loescher
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Feike Sijbesma
Mr. Feike Sijbesma
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Ms. Sock Koong Chua, CPA
Ms. Sock Koong Chua, CPA
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Indra K. Nooyi
Ms. Indra K. Nooyi
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Marnix van Ginneken, Ph.D.
Dr. Marnix van Ginneken, Ph.D.
Chief ESG & Legal Officer, Member of the Board of Management
Chief ESG & Legal Officer, Member of the Board of Management
--
--
Dr. Paulus A. (Paul) Stoffels
Dr. Paulus A. (Paul) Stoffels
Independent Vice Chairman of the Supervisory Board, Secretary
Independent Vice Chairman of the Supervisory Board, Secretary
--
--
Mr. Roy Jakobs
Mr. Roy Jakobs
Chairman of the Management Board, President, Chief Executive Officer
Chairman of the Management Board, President, Chief Executive Officer
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader Diagnosis and Treatment
Executive Vice President, Chief Business Leader Diagnosis and Treatment
--
--
Ms. Deeptha Khanna
Ms. Deeptha Khanna
Executive Vice President, Chief Business Leader Personal Health
Executive Vice President, Chief Business Leader Personal Health
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Koninklijke Philips NV?
Los cinco principales accionistas de Koninklijke Philips NV son: Dr. Marnix van Ginneken, Ph.D.
¿Cuántas instituciones poseen acciones de Koninklijke Philips NV (PHG)?
A fecha de 2026Q1, 590 instituciones poseen acciones de Koninklijke Philips NV, con un valor de mercado combinado de aproximadamente 50.72M, lo que representa el 5.33% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -11514508.00.